Announcements Trials
Browse Landscape

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Neoplasms 6Frailty 4Lymphoma 3Prostatic Neoplasms 2Ovarian Neoplasms 2Head and Neck Neoplasms 2Fallopian Tube Neoplasms 2Breast Neoplasms 2Urinary Bladder Neoplasms 1Prostate Cancer Cured 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Lung Neoplasms 1HER2 Positive Breast Carcinoma 1Colorectal Neoplasms 1

Interventions

Dexamethasone 363Bortezomib 232Lenalidomide 202Cyclophosphamide 174Melphalan 154Calcium Dobesilate 107Peripheral Blood Stem Cell Transplantation 92fludarabine phosphate 84Thalidomide 81Filgrastim 71carfilzomib 68pomalidomide 66Granulocyte Colony-Stimulating Factor 60Mycophenolic Acid 59Busulfan 57daratumumab 55Whole-Body Irradiation 54Tacrolimus 51ixazomib 50Prednisone 50Cyclosporine 49fludarabine 46Antilymphocyte Serum 35Etoposide 30dexamethasone acetate 29Methotrexate 29plerixafor 27Radiotherapy 26Doxorubicin 26dexamethasone 21-phosphate 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Multiple Myeloma × Geriatric Assessment × Clear all
NCT05918185 2026-02-03

Evaluation of Comprehensive Geriatric Assessment and Laboratory Biomarkers in Elderly Patients With Multiple Myeloma

Mayo Clinic

Completed
56 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡